Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands

A. Brian Jones,John J. Acton,Alan D. Adams,Winston Yuen,Elizabeth A. Nichols,Cheryl D. Schwartz,Linda S. Wicker,Jeffrey D. Hermes

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS（1999）

引用 6|浏览22

暂无评分

摘要

Tetrapeptide derived major histocompatability (MWC) II ligands have been developed that contain no unadulterated peptide bonds. These are the 'least peptidic' ligands for any NHC protein yet reported. (C) 1999 Elsevier Science Ltd. All rights reserved.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要